Clinical Trial Update: Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)

View source ↗

Summary

A retrospective Special Drug Use Investigation of fondaparinux (Arixtra) for venous thromboembolism treatment in patients over 100 kg has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Ataxia | Status: COMPLETED